Quantification of Microbiota in Health and Diseases
NCT03388424 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2020-09-16
Summary
Microbiota consists of trillions of microorganisms located in all the biological cavity. The relationships between individual health status and microbiota are based on a sort of "mutual cooperation." The balance of the microbiota can be compromised by various factors such as environmental, psycho-physical stress, malnutrition (over or low), breastfeeding, chronic diseases, oncology and pharmacological treatments (especially antibiotics and chemotherapics). The impact of dysbiosis on today's society affects over 70% of the world population
Conditions
- Disease
Interventions
- DIAGNOSTIC_TEST
-
quantification of microbiota
For each group a sample of biological sample will be take and will be analyzed using the n-counter flex platform in order to quantify disbiosis
Sponsors & Collaborators
-
Azienda Sanitaria Provinciale Di Catanzaro
collaborator OTHER -
University of Catanzaro
lead OTHER
Principal Investigators
-
Luca Gallelli, MD · University of Catanzaro
Eligibility
- Min Age
- 4 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-11-22
- Primary Completion
- 2020-05-21
- Completion
- 2022-11-21
Countries
- Italy
Study Locations
More Related Trials
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN
-
Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis
NCT06228937 ·Status: RECRUITING
-
Clinical and Biological Impact of Gut Microbiota in Adult Patients With Bacteremia During the COVID-19 Pandemic
NCT07183722 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Anaerobes in Different Clinicalsamples
NCT03266341 ·Status: UNKNOWN
-
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 ·Status: RECRUITING
-
Study of the Intestinal Microbiota
NCT07058961 ·Status: RECRUITING
-
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria
NCT03338738 ·Status: COMPLETED ·Phase: NA
-
Comparison of Different Methods for the Analysis of Gut Microbiome Composition
NCT04082221 ·Status: COMPLETED
-
The Urinary Microbiome and Its Relationship to the Urinary and Serum Metabolome in Healthy Peri- and Postmenopausal Women
NCT06573827 ·Status: NOT_YET_RECRUITING
-
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
NCT04623424 ·Status: RECRUITING
-
Uterine Microbiome in Women with Repeated Implantation Failure and Normal Fertile Women
NCT03405883 ·Status: COMPLETED
-
Collection of Microbiome Samples of Healthy Western Donors for Fundamental and Functional Microbiome Research
NCT06466707 ·Status: RECRUITING ·Phase: NA
-
Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs
NCT07093593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Human Microbiota and Liver Transplant
NCT02223468 ·Status: COMPLETED
-
Existence in the Human Digestive Flora of Phages Able to Prevent the Acquisition of Multiresistant Enterobacteria
NCT03231267 ·Status: UNKNOWN
-
Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics
NCT03967301 ·Status: UNKNOWN ·Phase: NA
-
Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?
NCT04699981 ·Status: UNKNOWN ·Phase: NA
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
Impact of Prolonged Antibiotic Therapy on Commensal Microbial Community Gene Expression.
NCT05169255 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiota in Acute Pancreatitis: Prospective Multicenter Study
NCT04038554 ·Status: UNKNOWN
-
From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis
NCT07313865 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Amplification and Selection of Antimicrobial Resistance in the Intestine II
NCT03140826 ·Status: COMPLETED
-
Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.
NCT02031588 ·Status: TERMINATED
-
Gut Microbiota Pilot Study
NCT03897023 ·Status: UNKNOWN
-
Enteric Microbiome and Liver Transplantation
NCT03666312 ·Status: UNKNOWN